Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Ketamine for Acute Management of Mood Disorders With Suicidal Ideation

NCT04099771 is registered in ClinicalTrials.gov with The Miriam Hospital as lead sponsor.

NCT NCT04099771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04099771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Ketamine for Acute Management of Mood Disorders With Suicidal Ideation
Lead sponsor
The Miriam Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
July 1, 2019
Completion date
December 31, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major, suicidal ideation